Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» KTE-X19
KTE-X19
Gilead’s Kite Pharma gets FDA nod for second CAR-T cell therapy
MedCity News
Sat, 07/25/20 - 02:29 pm
Gilead Sciences
CAR-T
KTE-X19
Tecartus
FDA
Kite Pharma
For Gilead, Its Coronavirus Treatment Is Icing on the Cake
Motley Fool
Fri, 03/27/20 - 10:56 am
Gilead Sciences
remdesivir
COVID-19
KTE-X19
magrolimab
FDA Speeds Up Examination of 5 Drugs with Priority Review
BioSpace
Thu, 02/13/20 - 12:24 am
FDA
priority review
capmatinib
Kite Pharma
KTE-X19
Eli Lilly
selpercatinib
GSK
belantamab mafodotin
Astex
C-DEC
FDA Grants Priority Review For Kite's KTE-X19 BLA
NASDAQ
Mon, 02/10/20 - 10:27 am
Gilead Sciences
Kite Pharma
KTE-X19
priority review
FDA
mantle cell lymphoma
Gilead's Kite files for FDA approval of second CAR-T therapy
Fierce Biotech
Thu, 12/12/19 - 11:27 am
Gilead Sciences
KTE-X19
mantle cell lymphoma
CAR-T
Kite Pharma
ASCO 2019 day two
Pharmaforum
Sun, 06/2/19 - 01:01 pm
Gilead Sciences
Kite Pharma
KTE-X19
CAR-T
ASCO 2019
Novartis
Merck
Keytruda
spartalizumab